Government Affairs & Public Policy Excellence: Optimizing Group Structure & Operations

Features:

14	Info Graphics
27	Data Graphics
151	Metrics
28	Narratives

Pages: 72

Delivery Format: Shipped

Call 919-403-0251

Government Affairs & Public Policy Excellence: Optimizing Group Structure & Operations

ID: PSM-252

Price:

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.

Businesses today face tougher regulations and scrutiny, which necessitates strong Government Affairs and Public Policy groups that can direct and oversee complex matters in regards to public policy and legislation. Government Affairs and Public Policy can ensure movement from a reactive to a proactive to a anticipatory stance with many of these outside organizations.

For Government Affairs and Public Policy to be effective, those leading the groups must be connected to their organization’s goals and corporate leadership -- which can be an ongoing and challenging process.

Best Practices, LLC conducted research to identify the functional factors that drive Government Affairs and Public Policy to better support the entire business operation.

Also, this study presents different organizational models for pharma Government Affairs and Public Policy groups and current trends in staffing and budgets for these groups as well.

Government Affairs and Public Policy leaders can use this research to compare their organizational structure and resourcing with those of leading organizations.

Benchmark Class
Study Snapshot
Key Findings
View TOC and List of Exhibits

Industries Profiled:
Health Care; Pharmaceutical; Diagnostic; Biotech; Chemical; Medical Device

Companies Profiled:
Abbott; DRI; Novo Nordisk; Biomarin; Genentech; AstraZeneca; Boehringer Ingelheim; Roche; UCB Pharma; GlaxoSmithKline; Solvay Pharmaceuticals; Stiefel; Pfizer; Lilly; Baxter International; Cephalon; Inc.

Study Snapshot

This benchmarking research included 16 Government Affairs and Public Policy executives and managers at 15 leading bio-pharmaceutical, healthcare and medical device companies.

Benchmark partners reflect functional experience that interacts directly or indirectly with the Government Affairs function. Because Government Affairs resides in different places across different companies, diverse functions from Government Affairs, Federal Affairs, Communications, Medical Affairs and Public Policy participated in this study.

Field interviews and study analysis produced many observations and benchmark findings. Key study insights reflect the inter-related evolution of a company’s commercial structure and how Government Affairs is organized to serve internal and external customers.

Sample Key Findings

Differentiated Services Are the Norm for Government Affairs: Almost three-quarters of participants said they vary the level of services – staffing, time, and responsiveness – across internal customers. The practice reflects the significant impact that Government Affairs can have on important business issues such as reimbursement and regulatory. It further underscores how small expert staffs provide services to diverse stakeholders while reflecting differences in stakeholder issues and impact.

Outsourcing Is an Emerging Staffing Tactic for Government Affairs in the U.S. Market: Outsourcing of Government Affairs staff is a viable staffing strategy in the U.S. marketplace but is less utilized outside U.S. markets. The maximum outsourced Government Affairs staff in the U.S. reached 51% at one benchmark company. Still others don’t outsource. The average mix is about 70% in-sourced and 30% outsourced in the U.S. Expanded outsourcing strategies are another approach to managing with reduced staffing resources.

Table of Contents

Project Blueprint

Executive Summary: Benchmark Insights and Research Group
Government Affairs Group Structures: Key Trends & Drivers of Sub-group Evolution
Government Affairs Group Models and Structures
Government Affairs & Policy Groups Staffing Benchmarks: Key Trends in Resourcing Government Affairs Groups
Government Affairs & Policy Funding Levels & Sources: Examining the Resources Invested for Success
Government Affairs & Policy Group Services: Trends in Service Levels & Key Priorities
Government Affairs & Policy Responsibilities: Trends in Forging Accountability & Clear Roles
Communicating the Value of Government Affairs & Policy In a Global Bio-Pharma Company
Contact Information

Related Research

Managing Healthcare Reform: Winning Strategies for Engaging the Government Ecosystem That Shapes Healthcare Policy

The influence of the Centers for Medicare and Medicaid Services (CMS) on healthcare policy and reimbursement is increasing as the US population ages and healthcare reform unfolds... (ID POP-246)
Companies Profiled: Amylin, Astellas, AstraZeneca, Bayer, read more ...

Price: $6500.00 Free Excerpt Available

Maintaining a Competitive Edge in Pharmaceutical Public Affairs: Benchmarking the Resources Required to Serve the U.S. Market

To ensure organizational health and competitiveness, companies must continually identify optimal resource levels for their operations... (ID PSM-222)
Companies Profiled: Abbott, Astellas Pharma, Boehringer Ingelheim, Cardinal Health, read more ...

Price: $5800.00 Free Excerpt Available

Government Affairs & Public Policy Excellence: Optimizing Group Structure & Operations